Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mark L. Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre & Louis B. Chaykin. (2019) Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes. Current Medical Research and Opinion 35:9, pages 1623-1629.
Read now
Read now
Rosemarie Lajara, German Guerrero & Jerome Thurman. (2012) Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe. Expert Opinion on Drug Delivery 9:10, pages 1181-1196.
Read now
Read now
David Oyer, Marcus Niemeyer & Alan Moses. (2012) Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens. Postgraduate Medicine 124:5, pages 110-120.
Read now
Read now
Articles from other publishers (11)
Aurore Lesage, Brice Leclère, Leïla Moret & Clément Le Glatin. (2021) Decreasing patient-reported burden of treatment: A systematic review of quantitative interventional studies. PLOS ONE 16:1, pages e0245112.
Crossref
Crossref
Jieling Chen, Ludi Fan, Xiaomei Peng, Liza Ilag, Trang Ly & Jennal Johnson. (2020)
Patient‐reported
outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes
. Diabetes, Obesity and Metabolism 23:1, pages 240-244.
Crossref
Crossref
Arvind GuptaSanjeev PhatakY. Sadashiv RaoJayanthy Ramesh & Debmalya Sanyal. (2020) Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India. Diabetes Technology & Therapeutics 22:10, pages 777-786.
Crossref
Crossref
Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Evan W. Davies & Rosirene Paczkowski. (2017) Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes. BMC Health Services Research 17:1.
Crossref
Crossref
Adem Sav, Asiyeh Salehi, Frances S. Mair & Sara S. McMillan. (2017) Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature. BMC Medical Research Methodology 17:1.
Crossref
Crossref
Niels GudiksenThibaud HofstätterBirgitte B. RønnThomas Sparre. (2017) FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions. Diabetes Technology & Therapeutics 19:10, pages 603-607.
Crossref
Crossref
Colin H. Ridyard, Dalia M. M. Dawoud, Lorna V. Tuersley & Dyfrig A. Hughes. (2016) A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration. The Patient - Patient-Centered Outcomes Research 9:4, pages 281-292.
Crossref
Crossref
Morihiro Okada, Masae Okada, Jun Nishigami, Naoto Yamaaki, Kenji Furukawa, Kiminori Ohyama, Tsutomu Shimada & Yoshimichi Sai. (2015) Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus. Journal of Pharmaceutical Health Care and Sciences 1:1.
Crossref
Crossref
Marina Vladimirovna Shestakova, Michail Vladimirovich Antciferov, Alexander Yur'evich Mayorov, Luydmila Alexandrovna Ruyatkina, Ludmila Alexandrovna Suplotova, Sergey Anatol'evich Dogadin, Nikolay Borisovich Lebedev & Yana Gennadievna Alekseeva. (2015) Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes. Diabetes mellitus 18:4, pages 130-141.
Crossref
Crossref
Ippei Kanazawa, Masakazu Notsu, Ken-ichiro Tanaka, Nobuaki Kiyohara, Yuko Tada & Toshitsugu Sugimoto. (2015) An Open-label Longitudinal Study on the Efficacy of Switching from Insulin Glargine or Detemir to Degludec in Type 2 Diabetes Mellitus. Internal Medicine 54:13, pages 1591-1598.
Crossref
Crossref
Athena Philis-Tsimikas, Meryl Brod, Marcus Niemeyer, Ann Marie Ocampo Francisco & Jeffrey Rothman. (2013) Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use). Advances in Therapy 30:6, pages 607-622.
Crossref
Crossref